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Confocal imagingThe afﬁnity of peripheral membrane proteins for a lipid bilayer can be described using the partition coefﬁcient
(KP). Although several methods to determine KP are known, all possess limitations. To address some of these
issues, we developed both: a versatile method based on single molecule detection and ﬂuorescence imaging
for determining KP, and a simple measurement standard employing hexahistidine-tagged enhanced green ﬂuo-
rescent protein (eGFP-His6) and free standing membranes of giant unilamellar vesicles (GUVs) functionalized
with NTA(Ni) lipids as binding sites. To ensure intrinsic control, our method features two measurement
modes. In the single molecule mode, ﬂuorescence correlation spectroscopy (FCS) is applied to quantify free
andmembrane associated protein concentrations at equilibrium and calculate KP. In the imaging mode, confocal
ﬂuorescence images of GUVs are recorded and analyzed with semi-automated software to extract protein mean
concentrations used to derive KP. Both modes were compared by determining the afﬁnity of our standard,
resulting in equivalent KP values. As observed in other systems, eGFP-His6 afﬁnity for membranes containing
increasing amounts of NTA(Ni) lipids rises in a stronger-than-linear fashion. We compared our dual approach
with a FCS-based assay that uses large unilamellar vesicles (LUVs), which however fails to capture the
stronger-than-linear trend for our NTA(Ni)-His6 standard. Hence, we determined the KP of the MARCKS effector
domainwith our FCS approach onGUVs, whose results are consistent with previously published data using LUVs.
We ﬁnally provide a practical manual on how to measure KP and understand it in terms of molecules per lipid
surface.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Peripheral membrane proteins are involved in various key cellular
processes, e.g. signaling and cell division [1,2]. They can interact with
lipid membranes in different ways, for example by lipid modiﬁcations
or through membrane targeting domains. Besides a direct interaction
with a speciﬁc lipidmolecule (e.g. proteins recognizing phosphoinositol),acid, succinimidyl ester; BSA,
ctadecenoyl)-sn-glycero-3-[(N-
] nickel salt; DOPC, 1,2-di-(9Z-
exahistidine-tagged enhanced
ion spectroscopy; GUV, giant
tion rate constant; kon, associa-
unilamellar vesicle; MARCKS,
lotriacetic acid; PBS, phosphate
-3-phosphocholine; POPS, 1-
e).
nstitute of Biotechnology and
z, Austria.
-82377 Penzberg, Germany.the membrane binding site of a protein can interact with several outer
head groups (e.g. BAR proteins) [3] and/or with the internal hydrocarbon
backbone of a lipid area [4–6]. The quantiﬁcation of membrane afﬁnity of
peripheral proteins is challenging but crucial, in order to elucidate the role
of lipid composition and the properties of anchoring segments on bind-
ing speciﬁcity. The partition coefﬁcient (KP) is an important generic
parameter that describes the afﬁnity of a molecular species for lipid bi-
layers independently from the underlying binding mechanism [7]. For
KP determination in model membrane systems, several methods are
known, e.g. ﬂuorescence spectroscopy, equilibrium dialysis, centrifuga-
tion or calorimetry. Besides speciﬁc advantages, all of them have partic-
ular experimental drawbacks, such as changes in lipid and/or protein
concentration during the measurement, and low sensitivity. These
methods, their advantages and drawbacks were discussed in detail in
several review articles [7–11].
Besides the above-mentioned established approaches, few additional
microscopy basedmethods have been proposed to determine the afﬁnity
of diverse molecular species for lipid membranes. A quantitative ﬂuores-
cence recovery after photobleaching (FRAP) approach was applied in live
cells to obtain the association anddissociation rate constants kon and koffof
intracellular binding-reaction diffusion process [12]. Total internal reﬂec-
tion ﬂuorescence (TIRF) imaging was used to determine the membrane-
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layers [13]. Finally, confocal imaging of single liposomeswas employed to
investigate curvature sensing motifs [14]. However, none of these assay-
speciﬁc microscopy based methods is generally applicable to determine
arbitrary KPs.
Fluorescence Correlation Spectroscopy (FCS), on the other hand, has
been used to determine the KP of ﬂuorescently labeled peptides to LUVs
[15]. In this approach the vesicle-bound and free peptide fractions can
be distinguished by their different correlation times. This method offers
appealing advantages (e.g. measurement time, extended accessible
concentration range) and could be successfully applied for several pro-
tein–lipid systems [1,2,16–18] as well as combined with ﬂuorescence
spectroscopy to dissect complex partitioning modes [19]. However,
potential pitfalls in the data analysis were reported [4–6,20–22]. In
our experience, protein-induced vesicle aggregation, as well as varia-
tions in protein concentration throughout the measurements, are
experimental challenges whichmay sometimes preclude this approach.
A generalized method that still proﬁts from the advantages of using FCS
to study membrane dynamics [7–10,23–25], e.g. sensitivity, and at the
same time overcomes the above-mentioned limitations is desirable.
Here we describe a new and robust assay, suitable for experimental
situations where other methods are not practicable, enabling the direct
extraction of quantitative information from the protein systems
reconstituted in giant unilamellar vesicles (GUVs). This well-established
model membrane system possesses the advantage to be free standing,
and thus, protein–lipid interactions are not affected by any support.
GUVs have a diameter of 1–100 μm, which easily allows imaging by con-
focal ﬂuorescence microscopy and permits the simultaneous measure-
ment of both free and bound protein fractions. Also, protein association
to GUVs is hardly affected by curvature, the GUV membrane being virtu-
allyﬂat on thenanoscale. Furthermore, GUVs can inprinciple beproduced
with any biologically relevant lipid composition and by various methods
[12,26].
In our assay, the concentrations of both free and GUV-bound protein
are determined at increasing protein concentrations via FCS or confocal
ﬂuorescence microscopy. Both approaches provide the advantages to ac-
count for potential loss of protein during the measurement (e.g. by pro-
tein interaction with the surface of the measurement chamber) as well
as for changes in the lipid concentration (e.g. by GUV bursting), and to
be sensitive down to nanomolar range. In addition, the partition coefﬁ-
cient can be directly calculated from the measured concentrations,Fig. 1. Schematic representation of (A) the lipid bilayer consisting of DOPC (gray head group), D
ordinating to NTA and to two histidines of His6-tagged eGFP, and (B) the three applied methodwithout the need for physical separation of membrane associated and
free protein or for change in the optical properties of the protein upon
membrane association. For the validation of the method, we chose the
well-characterized and easy to reproduce system of hexahistidine-tag
(His6) binding to nickel (Ni) chelated with nitrilotriacetic acid (NTA)
[27,28]. We used enhanced green ﬂuorescent protein (eGFP) with a
C-terminal His-Tag (eGFP-His6) as membrane associating protein and
GUVs containing 2–5 mol% NTA(Ni) functionalized lipid as membrane
model (Fig. 1A). His6-tagged proteins and NTA(Ni) functionalized lipids
are extensively used to reconstitute protein systems in GUVs [29–31]; in
particular eGFP-His6 attached to GUVs containing 20 mol% DGS-
NTA(Ni) was recently used as a simpliﬁed model system to mimic the
membrane bending property of the peripheral proteins Epsin1 and
AP180 [32]. To prove the accuracy of our results, we performed the LUV
assay [15], whose data analysis was improved to take into account multi-
ple binding of molecules to a single vesicle. Finally, we applied our meth-
od to determine the KP of the effector domain of the natural peripheral
MARCKS protein, MARCKS(151–175), and compared our results with
published values [15,33].
2. Theory
The afﬁnity of molecular species for membrane surfaces is described
by the relation between the concentration [Pf] (mol/m3) of the unbound
species freely diffusing in solution, and the concentration [Pm] (mol/m3)
of themembrane associated fraction. If the total accessible lipid concen-
tration [L] (mol/m3) is sufﬁciently large [L]≫ [Pm], so that no saturation
of the binding sites under the used experimental condition takes place,
and given that the volume and [L] of the system are kept constant, the
relation between the two concentrations is linear:
Pm½  ¼ α P f
 
: ð1Þ
The proportionality constant α is dimensionless and depends on the
amount of surface (expressed, for example, by the lipid concentration)
and on the characteristics of the interaction between the molecule and
the surface. The same relationship holds in case of partitioning between
two phases, i.e. aqueous and lipidic, which is described by KP as follows:
KP ¼ Pm½ = L½ P f
 
= W½  : ð2ÞGS-NTA(Ni) (blue) and the membrane dye ATTO-647N-DOPE (red), illustrating Ni2+ co-
s to determine KP.
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tions can be found inWhite and colleagues [7]. Thewater concentration
[W] is constant with [W]=W=55.5 M. [L] is also constant in a given
sample and can be expressed by:
L½  ¼ A
ALNA V
: ð3Þ
In Eq. (3),A is the total accessible lipid area,AL is the area per lipid,NA
is the Avogadro's constant and V is the volume of the sample chamber.
The importance of Eq. (2) is that it does not make any assumptions
about the binding stoichiometry, which is essential since various
modes of interaction may play a role in the binding of the same protein
to lipid membranes [3].
A convenient way to determine the concentrations in question is to
conduct FCS measurements. [Pf] can be quantiﬁed performing FCS on
free molecules in solution, whereas [Pm] can be obtained by measuring
on themembrane of the GUVs. Conveniently, in our assay it is sufﬁcient
tomeasure the surface concentration [P2D] (mol/m2) on the top pole of a
GUV instead of determining [Pm].
[P2D] can be converted to [Pm] bymultiplyingwith the total accessible
lipid area A:
Pm½  ¼ P2D½  AV : ð4Þ
A rearrangement of Eq. (2) yields in analogy to Eq. (1):
Pm½  ¼ KP L½ W P f
 
: ð5Þ
Combining Eq. (5) with Eqs. (3) and (4) gives the following main
equation (A and V cancel out):
P2D½  ¼ KPAL NA W
P f
 
: ð6Þ
Thus, measuring a set of [P2D]/[Pf] pairs for several concentrations of
the binding species leads to a linear behavior with slope:
a ¼ KP
AL NA W
: ð7Þ
When the AL for the used lipid mixture is known, KP can be obtained
from a, which is not dimensionless (unit of length (m)) but is analog to
α. Moreover, 1ALNA is the lipid surface concentration [L2D] (mol/m
2),
which is constant for a given lipid mixture. Therefore by knowing KP
and [Pf] of the system, one can always calculate thenumber ofmolecules
per lipid surface, which depends on the combined constant c ¼ ½L2D W (see
Supplementary information, Fig. S1B):
P2D½  ¼ c KP P f
 
: ð8Þ
Alternatively, both [Pf] and [P2D] can be determined imaging GUVs at
their equator. A similar approachwas reported for analysis of living cells
[15,34]. When a GUV is imaged at its equatorial plane, the ﬂuorescence
intensities of its surface and of the surrounding solution are proportion-
al to the concentrations of themembrane bound [Pm] and freemolecules
[Pf], respectively.
3. Materials and methods
3.1. Materials
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine (DOPC),
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)
iminodiacetic acid)succinyl] nickel salt (DGS-NTA(Ni)), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho-L-serine (POPS) and Avanti Mini-Extruder were
purchased from Avanti Polar Lipids (Alabaster, AL). Alexa Fluor 488 car-
boxylic acid, succinimidyl ester (Alexa488) was obtained from Life Tech-
nologies GmbH (Darmstadt, Germany); ATTO-488-NHS, ATTO-655 and
ATTO-647N-DOPE fromATTO-Tec (Siegen, Germany). Albumin from bo-
vine serum (BSA) was ordered from Sigma-Aldrich (Schnelldorf,
Germany). pGEX-6P-1 vector, Glutathione Sepharose 4 Fast Flow,
PreScission Protease and 100 nm polycarbonate membrane were
purchased from GE Healthcare (Little Chalfont, United Kingdom).
3.2. eGFP-His6 cloning, expression and puriﬁcation
eGFP-His6 was cloned into the pGEX-6P-1 vector using the restric-
tion enzymes SalI and NotI and expressed in the Escherichia coli strain
BL21(DE3). The protein was puriﬁed using Glutathione Sepharose 4
Fast Flow according to the manufacturer's instructions, followed by
direct cleavage of the glutathione S-transferase tag with PreScission
Protease on the column.
3.3. Synthesis and labeling of the MARCKS peptide
The peptide corresponding to the effector domain of the MARCKS
protein, MARCKS(151–175) was synthesized with an extra GS linker
at the N-terminus using Fmoc-chemistry and labeled at the N-
terminus using an ATTO-488-NHS-ester. This is the region of the pep-
tide being most distal to the membrane when the peptide binds and
its partition coefﬁcient was shown to not signiﬁcantly vary from that
of radioactively NEM-labeled MARCKS(151–175) (Fig. 1C of Ref [15]).
The C-terminus was blocked with an amide group, producing a peptide
with 13 positive and zero negative charges. ATTO-488 has one positive
and two negative charges at pH 7. The peptide was puriﬁed to N90%
by preparative RP-HPLC. Purity and identity of the peptide were
checked by analytical RP-HPLC and electrospray mass spectrometry.
The peptide was stored at−80 °C lyophilized or in water at 1 mg/ml
ﬁnal concentration.
3.4. Preparation of model membranes
3.4.1. Giant unilamellar vesicles
GUVs were prepared by the electroformation method [35]. Brieﬂy,
5 μl of the corresponding lipid mixture (2 mg/ml in chloroform) was
spread and dried onto two Pt-wires and put into a homemade teﬂon
chamber ﬁlled with 350 μl of 300 mM sucrose. An AC electric ﬁeld of
2 Vwas applied to the chamber at a frequency of 10 Hz for 1 h, followed
by 2 Hz for 0.5 h. Experiments were carried out in 120 μl MatriCal 384-
multiwell plates (Matrical biosciences — now Brooks Life Science Sys-
tems, Spokane, USA). For the NTA(Ni)-His6-system, DOPC and 2, 3, 4
or 5 mol% DGS-NTA(Ni) were mixed and labeled with 0.05 mol%
ATTO-647N-DOPE. The wells were passivated with 2 mg/ml BSA for at
least 30 min and washed two times with phosphate buffered saline
(PBS — 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4,
pH 7.4). The obtained GUVs were diluted 1:50 in sucrose solution and
then 1:3 in PBS buffer. Into a well containing 80 μl of PBS buffer 20 μl
of the GUV dilution in PBS was added. In case of the MARCKS peptide,
GUVs contained 5, 12.5 or 20 mol% POPS in POPC and 0.01 mol%
ATTO-647N-DOPE as a lipid dye. The wells were passivated with
0.53 mg/ml POPC small unilamellar vesicles over night and washed
ten times with working buffer (10 mM HEPES pH 7, 100 mM NaCl).
The obtained GUVswere diluted 1:10 in sucrose and 20 μl of the dilution
was transferred into a well, containing 80 μl of working buffer.
3.4.2. Large unilamellar vesicles
DOPC and 2, 3, 4 or 5 mol% DGS-NTA(Ni) weremixed in chloroform.
After solvent evaporation, the lipid ﬁlm was rehydrated in PBS buffer at
10 mg/ml lipid concentration and resuspended by vortexing. The
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extruded 21 times through a polycarbonate membrane. LUV size and
monodispersity were checked via dynamic light scattering (DynaPro
NanoStar™, Wyatt Technology Corporation, Santa Barbara, CA) and
lipid concentration in LUV preparations was determined by phospho-
rous assay [36] after extensive dialysis in the presence of non-
solubilizing concentrations of TritonX-100. The measured LUV size
and lipid concentration were used to calculate the accessible LUV con-
centration [LUV] [37] and the number of lipids contained in a LUV
NLUV. Experiments were carried out in homemade observation cham-
bers obtained by gluing cut PCR tubes on a #1.5 coverslip (Gerhard
Menzel GmbH, Thermo Fisher Scientiﬁc, Braunschweig, Germany)
with a UV optical adhesive (NOA63, Norland Products Inc., Cranbury,
NJ). The wells were passivated with a 2 mg/ml BSA solution for at
least 30 min and rinsed with water and PBS. LUVs were 10-fold serially
diluted in PBS, incubated at the desired ﬁnal concentrationswith 50 nM
eGFP-His6 and transferred in the homemade observation chambers.
3.5. Fluorescence measurements
3.5.1. Optical setup
All measurements were carried out on a commercial laser scanning
microscope LSM 780 with a ConfoCor 3 unit (Zeiss, Jena, Germany)
using a water immersion objective (C-Apochromat, 40×/1.2 W
UV–VIS–IR, Zeiss, Jena, Germany). A λ/4 plate was implemented into
the light pass to excite by circularly polarized light and ensure uniform
excitation. Samples were excited by 488 nm line of an Ar-ion-laser
(ﬂuorescence detection range: FCS-GUV 505–575 nm, FCS-LUV
505–610 nm, imaging 491–569 nm) and by 633 nm line of a He–Ne
laser (ﬂuorescence detection range: FCS-GUV LP655 nm, imaging
638–759 nm). Laser powers were kept very low in order to avoid laser
power related problems such as in focus bleaching or saturation [38].
The experimentswere carried out at 26.0±0.5 °C,measured in solution
with a digital electrode thermometer Voltcraft K202 (Conrad Electronic,
Hirschau, Germany). The setup was calibrated using aqueous solutions
(~50 nM) of freely diffusing Alexa488 (D = 435 μm2/s 22.5 ± 0.5 °C
[39]) and in case of the GUV assay free ATTO-655 (D = 426 μm2/s
25 °C [40]) in a 1:1 ratio. The objective correction collar and the pinhole
position (d = 35 or 40 μm for the 488 line alone or both laser lines, re-
spectively) were adjusted to maximize the ﬂuorescence intensity.
Correction of diffusion coefﬁcients to the measurement temperature
[38], allowed us to determine the parameters of the detection volume:
the focal waist w0 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4DτD
p
, the focal volume VFCS ¼ π3=2Sw03 with
the structural parameter S and the focal areaAFCS ¼ πw02 after aweight-
ed ﬁt of the auto-correlation curves (Alexa488: 3D+ T diffusionmodel,
ATTO-655: 3D diffusion model without triplet correction).
3.5.2. GUV data acquisition and analysis by FCS
Per sample a minimum of eight GUVs were selected and measured
by point FCS at least at ﬁve increasing concentrations of protein. The
background signals in solution and on themembranewere recorded be-
fore protein addition, since especially at lowprotein concentrations, and
therefore at low ﬂuorescence intensities, the ﬂuorescence background
will affect the particle number obtained from the ﬁt. We used PyCorrFit
0.7.4 [41] to analyze the auto-correlation curves and Origin 9.0G for
ﬁtting.
Protocol to measure KP by Fluorescence Correlation Spectroscopy in
GUVs
1. Determine the number of particles Nf freely diffusing and their
diffusion time τD from a point-FCS measurement of ten times 30 s in
solution. Use a non-weighted ﬁt of the ﬂuorescence auto-correlation
curves with the suitable FCS model function for 3D + T diffusion to
obtain the number of free particles Nf' in the observation volume
and a weighted ﬁt to get τD. Remove the after pulsing (2 μs), ﬁx τTto 0.02 ms and S to the value obtained in the calibration measure-
ment. Correct Nf' for the background [42] to get Nf
2. Calculate [Pf] from Nf as follows:
P f
  ¼ Nf
VFCSNA
ð9Þ
3. Determine the number of particles N2D bound to a GUV from a point-
FCS measurement of ﬁve times 30 s at the top pole of the GUV [38].
Use a combined 2D–3D ﬁt, since both, freely diffusing molecules
and membrane bound molecules will be present in the detection
volume, ﬁxing τD to the value obtained in solution. From the ﬁt, the
fraction F of free protein in solution and the total particle number
N2D3D
' in the focal volume will be obtained. Since τD is obtained by
an external measurement and differs by at least an order of
magnitude from the 2D diffusion time in themembrane, F is robustly
determined under particle counts recommended for FCS [43]. After
correcting N2D3D' for the background, the particle number N2D in
the FCS observation area AFCS can be calculated:
N2D ¼ 1−Fð ÞN2D3D ð10Þ
4. Use N2D to calculate [P2D]:
P2D½  ¼ N2DAFCSNA
ð11Þ
5. Plot [Pf] against [P2D] and ﬁt the graph with a x/y-weighted linear
model to obtain the slope a.
6. Knowing AL, calculate KP from the slope a
KP ¼ a AL NA W: ð12Þ
3.5.3. GUV data acquisition and analysis by Image Analysis
Images of the same GUVs as in the GUV–FCS approachwere taken at
approximately their equator using avalanche photodiodes as detectors
in the confocal microscope. In order to extract the membrane bound
and free ﬂuorescence intensities I2D and If from the confocal GUV
images, a semi-automated software was developed (Fig. 2).
Each I2Dwas correlated to the corresponding concentration [P2D] de-
termined by FCS in Origin 9.0G and analyzed by a linear ﬁt passing
through the origin of the graph. Analogously the averaged mean
intensities in solution If were related to [Pf].
Protocol to calibrate the Image Analysis in GUVs
1. Determine [P2D] and [Pf] of several GUVs by FCS as described in the
“Protocol to measure KP by Fluorescence Correlation Spectroscopy in
GUVs” or by any other method of choice.
2. Take images of the sameGUVs at approximately their equator using a
photon counting detector (i.e. avalanche photodiodes).
3. Extract the surface and free ﬂuorescence intensities I2D and If from
the confocal GUV images, using for example our semi-automated
software (the Matlab source is available upon request). For each
GUV to analyze, the user enters approximate coordinates of the
GUV center and an approximate radius. The software then
determines the precise GUV center position and approximates the
circumference of the GUV cross-section by a smooth closed curve.
This allows the extraction of the radial intensity proﬁle of the GUV.
From the intensity proﬁle the surface ﬂuorescence intensity I2D and
the solution ﬂuorescence intensity If are determined. Additionally,
it is possible to exclude a range of angles (`a wedge’) from the
analysis, which is useful, for example, when two GUVs are in contact.
The ring region outside the GUV (an interval of radial distance in the
Fig. 2. GUV image analysis. (A) GUV with rescaled intensity, (B) the ring area between the two dashed lines is used to determine the surface concentration (bound fraction, I2D), the mean
intensity inside theGUV is calculated from the innermost ring area, and the intensity outside theGUV from the outermost ring, (C)ﬁt of theGUV shape and intensitywithin the selected area,
(D) ﬁt residuals, (E) the experimental (blue) and ﬁtted (red) radial proﬁle of GUV. Image scale: (A)–(D) x- and y-axis in pixel, (E) x-axis in pixel and y-axis in average photons per pixel.
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constant for all GUVs and need not be adjusted individually.
4. If necessary subtract the background of the GUVs before protein
addition from the mean intensities.
5. Plot I2D and If intensities against [P2D] and [Pf] concentrations
determined by FCS or by another method, respectively and ﬁt each
graph with a linear model passing through the origin of the graph
to obtain the two proportionality constants b2D and bf.
Protocol to measure KP by Image Analysis in GUVs
1. Repeat steps 2–4 of the “Protocol to calibrate the Image Analysis in
GUVs” for several GUVs
2. Calculate [P2D]=b2DI2D and [Pf]=bfIf
3. Repeat steps 5–6 of the “Protocol to measure KP by Fluorescence
Correlation Spectroscopy in GUVs”
3.5.4. LUV data acquisition and analysis
For each DOPC:DGS-NTA(Ni) molar ratio, at least three independent
samples were investigated at eight different LUV concentrations (1 μM–
10 mM). For each LUV concentration, point-FCS was measured four
sequential times and for each of them ten independent ﬂuorescence in-
tensity tracks of 10 s each were acquired. The FCS auto-correlation
curves were calculated using the Zeiss ZEN 2011 Black edition software
and analyzed using PyCorrFit 0.8.1 [41] and SigmaPlot 12.3 (Systat
Software, Inc., San Jose, CA).
Protocol tomeasureKP by Fluorescence Correlation Spectroscopy in LUVs
1. Determine the protein concentration [P] and the diffusion time of the
free protein τf from the point-FCS measurements of a solution of the
protein in the absence of LUVs. Use a non-weighted 3D+ T-ﬁt to get
the number of particles N, and a weighted ﬁt to get the τf, ﬁxing S to
the value obtained in the calibration measurement. [P] can be
calculated from N as follows:
P½  ¼ N
VFCSNA
ð13Þ
2. Determine the total number of particles Nf+m (free + vesicle bound
protein) from the point-FCS measurements of a solution of the pro-
tein in the presence of different concentrations of LUVs. Use a non-weighted two components 3D + T-ﬁt, ﬁxing S and τf to the values
obtained in the calibration measurements and in the absence of
LUVs, respectively.
3. Calculate an average G(0) value for each LUV concentration of a
sample and normalize by the G(0) value in the absence of LUV
using G
0 ð0Þ ¼ NN fþm.
4. To obtain Kd, plot the G'(0) values against the accessible LUV
concentration and ﬁt, ﬁxing [P] to the value obtained in the absence
of LUVs, with the following equation:
G0 0ð Þ ¼ 1þ P½  LUV½ 
Kd þ LUV½ ð Þ2
ð14Þ
5. If needed convert the obtained Kds to KP:
KP ¼ WNLUVKd
ð15Þ
NLUV is the number of lipids contained in a LUV.
4. Results and discussion
4.1. GUV based assay by FCS
For the calculation of the partition coefﬁcient KP, it is essential to pre-
cisely determine the amount of both freely diffusing and DGS-NTA(Ni)-
coordinated eGFP-His6. In order to quantify both concentrations, we
conducted point-FCS in solution and on the top pole of several GUVs
per probe.
Before measurement of each sample, the system was carefully
calibrated with Alexa488 to calculate the focal waist w0, VFCS and AFCS.
The latter two need to be determined precisely, since an error of their
values propagates in the calculation of all protein concentrations. Here
it is of importance to rely on dyes with a well known diffusion coefﬁ-
cient and correct for its temperature dependency [38,43]. The average
values obtained of all measurements are w0=218.0±6.0 nm
(mean ± s.e.m., n = 19), VFCS=3.98±0.36 ⋅10−19m3 (mean ± s.e.m.,
n = 19) and AFCS=1.49±0.08 ⋅10−13m2 (mean ± s.e.m., n = 19). As
Fig. 3. eGFP-His6 concentrations determined by GUV–FCS assay. [P2D] plotted vs. [Pf] for an
individual sample of 2% DGS-NTA(Ni). Error bars represent the standard deviation. The
ratio of [P2D]/[Pf] stays constant with increasing protein concentration. No saturation
occurs.
Table 1
Comparison of KPs. Calculated partition coefﬁcients by ﬁtting all data points for increasing
amounts of DGS-NTA(Ni) via the GUV and LUV methods (mean ± combined s.e.m.).
DGS-NTA(Ni) AL KP GUV–FCS KP GUV-imaging KP LUV–FCSa
2% 72.2 Å2 2.54 ± 0.27 · 106 2.79 ± 0.10 · 106 1.33 ± 0.23 · 106
3% 72.0 Å2 4.34 ± 0.88 · 106 4.56 ± 0.34 · 106 1.74 ± 0.10 · 106
4% 71.9 Å2 1.54 ± 0.11 · 107 1.35 ± 0.05 · 107 1.90 ± 0.18 · 106
5% 71.8 Å2 4.82 ± 1.13 · 107 3.55 ± 0.14 · 107 2.21 ± 0.22 · 106
a The differences at higher DGS-NTA(Ni) molar fraction (3–5mol%) between GUV- and
LUV- assay are due to protein-induced LUV aggregation (see Section 4.5 and Fig. S2).
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ATTO-655 having a focal waist w0=246.2±4.6 nm (mean ± s.e.m.,
n = 19) due to greater diffraction.
Thereafter, an overall image of thewell inwhich the experimentwas
carried out was taken by a tile scan. Sequentially, more GFP-His6 was
added into the chamber and incubated until equilibrium was reached.
For each protein concentration, the auto-correlation functions of both
the free and bound protein signals were recorded. The system was
very stable over time and therefore for each of the increasing amounts
of protein exactly the same GUVs could be surveyed. Additionally, the
ATTO-647 N-DOPE signal was taken simultaneously to control the
state of the membrane upon protein binding. Protein and lipid average
diffusion coefﬁcients of this system were reported elsewhere [44].
Fluorescent lipids in traces are commonly used in the presence of
His6-tagged proteins reconstituted inGUVs [30,45] and are not reported
to interfere with their binding to DGS-NTA(Ni) lipids. Among several
ﬂuorescent lipids available, ATTO-647N-DOPE was chosen because it
has low triplet formation and it is spectrally well separated from eGFP
(product speciﬁcation, www.atto-tec.com). In case the ﬂuorescence
time traces showed a strange behavior, the curves of both channels
were rejected. At higher concentrations of DGS-NTA(Ni), the laser
power of the 488 laser line needed to be reduced to avoid detector
saturation, which does not signiﬁcantly affect the concentration
measurement by FCS, but has to be considered for the image analysis
by using an appropriate calibration curve.
The successive auto-correlation curves taken in solution were ﬁtted
using 3D function in PyCorrFit [41] and Eq. (13) to get [Pf]. The average
diffusion time of eGFP-His6 in solution is τD=1.23±0.02 ⋅10−4s
(mean ± combined s.e.m., n = 890), from which the average diffusion
coefﬁcient can be calculated. The obtained value of D=103±6µm2/s
(mean± combined s.e.m.; 26.0± 0.5 °C) is in agreementwith previous
measurement [39].
Analogously, the corresponding auto-correlation functions taken on
membrane were ﬁtted using 2D-3D ﬁt function to get the average
number of particles, which was used to calculate the bound protein
concentration [P2D] according to Eqs. (10) and (11).
In Fig. 3 a typical graph of a measurement is shownwith the obtain-
ed [Pf] and [P2D] plotted against each other. The relatively high error bars
for [P2D] are possibly a result of an− to some extent unavoidable −
uneven distribution of the DGS-NTA(Ni) among the GUVs in the sample
[46]. However, this emphasizes the need to minimize sample inhomo-
geneity in order to reduce the experimental error. As assumed in the
theory, the linear relation between [Pf] and [P2D] conﬁrms that no satu-
ration of the binding sites takes place.
To calculate the partition coefﬁcient KP for a particular percentage of
DGS-NTA(Ni), the slope a and AL for the given system are required. For
our calculations, we used 72.4 Å2 for DOPC [47] and for DGS-NTA(Ni)
an AL of 60.0 Å2 [48]. We estimated AL by linear interpolation of the
two values, yielding 72.2 Å2, 72.0 Å2, 71.9 Å2 and 71.8 Å2 for the molar
ratios 2%, 3%, 4% and 5% of DGS-NTA(Ni) in the lipidmixturewith DOPC.
Fitting all data points of at least three independent measurements
results in a slope a for the percentage of DGS-NTA(Ni), out of which
the KP was calculated using Eq. (12). In Table 1 and Fig. 4 the results
of our investigations are summarized. Identical values are gained by av-
eraging the individual measurements and using a combined standard
deviation, small variations are due to differences in sample size.
Our results clearly show that eGFP-His6 binds stronger to the
membrane of the GUVs with increasing amounts of DGS-NTA(Ni) in
the lipid mixtures. So far no KP was reported for eGFP-His6 coordinated
to DGS-NTA(Ni), but a direct comparison to the published Kd values is
feasible [44].
4.2. GUV based assay by image analysis
Besides the FCS on the top pole of the GUVs as described in the pre-
vious paragraph, we imaged the equator of the same GUVs. In Fig. 2A-Ethe typical output of the analysis of a GUV image is shown. It is
necessary to correlate only once the mean intensity obtained by image
analysis to the concentration determined by another method, in our
case FCS.
In Fig. 5 example plots of all pairs of data points for 2% DGS-NTA(Ni)
for [P2D] and [Pf] and their corresponding mean intensities I2D and If are
shown. The slope b obtained by a linear ﬁt does not depend on the
amount of DGS-NTA(Ni), neither for the free nor for the bound eGFP-
His6. Hence, the combined mean slope b2D and the mean intensity of
the membrane bound eGFP-His6 for a particular laser power can be
used to calculate the concentration of membrane bound protein [P2D].
Similarly, [Pf] can be determined using bf and the mean intensity of
the free eGFP-His6. Therewith KP was calculated as described for the
FCS approach. The results (Table 1) are equivalent to those obtained
by the FCS approach.
4.3. LUV based assay by FCS
To validate our assay,wemeasured the afﬁnity of eGFP-His6 for DGS-
NTA(Ni)-containing vesicles with an alternative LUV based assay [15].
Here, the calculation of Kp relies on the precise measurement of
the total amountNf+m of eGFP-His6 particles in solution; eGFP-His6 par-
ticles can be both freely diffusing or coordinated to the DGS-NTA(Ni)
embedded in the vesicles. In order to quantify the total amount of
eGFP-His6 particles, we performed one-color point-FCS in solution at
different time points per probe.
Before measuring each sample, the system was calibrated using
Alexa488 as described for the GUV based assay. The average values ob-
tained for all measurements are w0=205.7±1.6 nm (mean ± s.e.m.,
n = 15) and VFCS=2.98±0.10 ⋅10−19m3 (mean ± s.e.m., n = 15).
In contrast to theGUVbased assay, the amount of eGFP-His6was kept
constant and equilibrated with different LUV concentrations. In particu-
lar, eGFP-His6 was gently mixed with the vesicles and subsequently
Fig. 4.Kp determinedbyGUV assay. Graphic presentation of partition coefﬁcientKP obtain-
ed by ﬁtting of all data points from FCS analysis (ﬁlled squares) and image analysis
(circles) for a certain concentration of DGS-NTA(Ni). Error bars represent the combined
standard error of mean. KP shows a stronger-than-linear behavior. Results of LUV–FCS
are excluded, since they are presumably distorted by LUV aggregation (see Section 4.5
and Fig. S2).
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be evenly distributed all over the chamber and the binding equilibrium
would be reached faster. Moreover, to minimize changes in the totalFig. 5. Calibration curve for GUV-image analysis. Mean intensity obtained by image
analysis plotted against the concentration determined by FCS (A) on the membrane and
(B) in solution of all data points of 2% DGS-NTA(Ni). Both curves show a linear behavior
and the slopes b2D and bf are used to calculate the protein concentration directly from
the mean intensities.
Fig. 6. LUV–FCS assay. (A) auto-correlation curves obtained in solution for eGFP-His6 in the
absence (0 M) and presence of increasing amounts of LUVs (1 μM, 10 μM, 100 μM, 1 mM,
and 10mM). Solid lines are the best ﬁt of the data with a single (0M) or two-components
(all other curves) 3D diffusion model, (B) Normalized G(0) data points for a single 2%
DGS-NTA(Ni) sample are plotted against the ratio [LUV]/Kd. The solid line is the best ﬁt
of the data using Eq. (14), (C) Graphic presentation of partition coefﬁcients KPs obtained
from Kd (Eq. (15)).volume of the sample, each LUV concentration was sequentially probed
in a separate chamber; FCS measurements were performed always at
the same distance from the bottom of the chamber to avoid any surface
related dependencies [49,50]. In these conditions background correction
was not necessary, since the eGFP signal is stable and signiﬁcantly higher
than the background level.
The auto-correlation functions of eGFP-His6 in solutionwere record-
ed in the absence of LUVs andﬁtted using a 3D+T function to obtain [P]
and the average diffusion time τf=0.96±0.05 ⋅10−4s (D=110±
7 µm2/s; mean ± combined s.e.m.; 26.0 ± 0.5 °C), respectively. The
Fig. 7.MARCKS peptidemeasuredwith theGUV–FCS assay (black closed circles) are in line
with the values reported by Arbuzova et al. 2000 using sucrose loaded vesicles and
radioactively labeled peptides ([33], red open circles) and by Rusu et al. 2004 using the
LUV–FCS method ([15], estimated from Fig. 4 of the reference, blue open circles). Error
bars represent standard deviations.
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amounts of LUVs were ﬁtted with a two component 3D + T function,
keeping τf constant, to get the total number of eGFP-His6 particles
Nf+m. A fraction of the acquired auto-correlation functions were affect-
ed by eGFP-His6-induced LUV aggregation [22], as reveled by their
distorted form (Supplementary information, Fig. S2). These curves
were not included in the analysis. As expected, the eGFP-His6 diffusion
time increases upon binding to LUVs (Fig. 6A), as far as the vesicles
are signiﬁcantly larger than the protein. At the same time, Nf+m de-
creases, meaning that more than a single eGFP-His6 molecule bind
each LUV. At higher LUV concentration Nf+m starts increasing again to
reach the original value of freely diffusing eGFP-His6, suggesting that
upon further addition of LUVs the eGFP-His6 molecules redistribute so
that the probability of more than one eGFP-His6 binding to one LUV is
negligible (Fig. 6B).
From the total number of eGFP-His6 particle values measured in at
least three independent samples (e.g. Fig. 6B), a G(0) was calculated
for each LUV concentration and normalized to the G(0) in the absence
of LUVs. The data points were then ﬁtted with Eq. (14) to obtain Kd for
a particular percentage of DGS-NTA(Ni) in the lipidmixture. The protein
and accessible lipid concentration values used for the ﬁt were deter-
mined experimentally. The total protein concentrationswere calculated
from the number of eGFP-His6 particles measured by FCS in the absence
of LUVs, whereas the accessible lipid concentrations were obtained
measuring both the total lipid concentrations and vesicle sizes (see
Materials and methods section for details). The dissociation constant
Kd was ﬁnally transformed into KP values for comparison applying
Eq. (15) (Fig. 6C).
4.4. KP of the MARCKS peptide determined by the GUV–FCS assay
In order to prove the applicability of our method to biological
peripheral proteins, the molar partition coefﬁcients KP of the peptide
corresponding to the effector domain of the MARCKS protein,
MARCKS(151–175) was determined with the GUV–FCS approach.
Before measuring each sample, the system was calibrated using
Alexa488 as described for the NTA(Ni)-His6 system. The average values
obtained of all measurements arew0=219.0±7.0 nm (mean± s.e.m.,
n = 13), VFCS=3.43±0.39 ⋅10−19m3 (mean ± s.e.m., n = 13) and
AFCS=1.53±0.11 ⋅10−13m2 (mean± s.e.m., n = 13). MARCKS peptide
was added in several wells at different concentrations. The auto-
correlation curves taken in the absence of GUVs were ﬁtted using a 3D
model function in PyCorrFit [41] to get the average diffusion time of
the MARCKS peptide in solution. The obtained value of τD=64.3±
4.1 ⋅10−6s (mean± combined s.d., n= 23) is in agreementwith previ-
ously reported results [15]. The same amount of GUVs was next added
in each well and incubated until equilibrium was reached. To easily
identify the GUVs, an overall image of the well was taken by a tile
scan. For each GUV, the auto-correlation functions of both the free and
bound protein signal were recorded and analyzed as described for the
NTA(Ni)-His6 system. For these calculations, we used an AL of 68.3 Å2
for POPC [51] and of 62.7 Å2 for POPS [52]. We estimated AL by linear
interpolation of the two values, yielding 68.0 Å2, 67.6 Å2 and 67.2 Å2
for the molar ratios of 5%, 12.5% and 20% POPS in the lipid mixture
with POPC. KP values for each percentage of POPSwere calculated ﬁtting
at least three independent data sets (Fig. 7).
The obtained results are in linewith the values reported byArbuzova
et al. [33] using sucrose loaded vesicles and radioactively labeled
peptide and by Rusu et al. [15] using the LUV–FCS method.
4.5. Comparison of methods
In both GUV based approaches, GFP-His6 shows a strong afﬁnity for
the membrane, which derives from the nature of the His-tag NTA(Ni)
chelation, which is not purely electrostatic, but involves the formation
of a more stable coordination bond. GFP-His6 afﬁnity for the membraneincreases non-linearly with higher contents of nickel–lipid in the bilay-
er, as observed for theMARCKS peptide and in other systems [15,22]. B.
Ernst and colleagues analyzed the binding/dissociation of different
oligo-His-tags to NTA(Ni) [27] and showed that for high surface densi-
ties of NTA(Ni) a rebinding effect plays an important role. Under these
conditions eGFP-His6 might interact with several DGS-NTA(Ni)
[53,54]. Hence, for higher DGS-NTA(Ni) contents, the equilibrium is
strongly shifted to the bound fraction, resulting in a stronger-than-
linear increase of KP. The LUV assay failed to capture this trend.
The results obtained for GUVs and LUVs containing equal amounts of
DGS-NTA(Ni) are shown in Table 1. At low DGS-NTA(Ni) molar fraction
(2mol%), the KPs measured with both GUV- and LUV-methods differ by
a factor of two (GUV-method: 2.51±0.19 ⋅106; LUV-method: 1.33±
0.23 ⋅106), whereas at higher DGS-NTA(Ni) molar fraction (3–5 mol%)
they differ up to one order of magnitude. We assume that the observed
differences are an artifact of the LUV–FCS method, due to LUV aggrega-
tion, which increases with lower lipid/protein ratios [22] and higher
DGS-NTA(Ni) molar fractions (see Supplementary information, Fig.
S2). It was shown that vesicles containing DGS-NTA(Ni) can aggregate
after addition of synthetic peptides with poly-histidine residues and
that the aggregation is dependent on the DGS-NTA(Ni) amount present
in the vesicles [55]. Therefore, the measured total number of eGFP-His6
particles in solutionNf+m, which is critical for deriving KP, does not only
dependon the lipid bindingproperties of the protein, but it is inﬂuenced
by the amount of protein and vesicles sequestered in the aggregated
form. In contrast to LUVs, no lipid or protein aggregation takes place
in GUVs upon eGFP-His6 binding. When the ligand does not induce
LUV aggregation as in case of the effector domain of the MARCKS pro-
tein, MARCKS(151–175) [15], the KP values obtained by the GUV- and
the LUV–FCS approach are comparable (Fig. 7). On the other hand,
in both GUVs based approaches, the protein and accessible lipid concen-
trations need to be carefully chosen in order to measure precisely in
solution and at the membrane. For high binding afﬁnities, the concen-
tration at the membrane could be already high while there are no
detectable amounts of proteins in solution, which set the upper range
of accessible KP to approximately 108. Interestingly the GUV–FCS
approach appears to be less precise than the GUV-imaging one, as
shown by the relatively high error bars for [P2D]. This can be explained
taking into account how the free protein concentration is measured in
the FCS and imaging approaches, only once for the whole chamber
and close by each GUV, respectively. Technically it should be enough
tomeasure the free protein concentration once, butmore precise values
can be determined with the GUV-imaging approach. The precision of
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to each GUV (Fig. 7), but this doubled the measuring time.
Importantly, both GUV based approaches possess the advantage
over the LUV method of directly visualizing the binding event and
thus of being able to correct anomalies in the sample. Having an over-
view of the whole chamber, it is possible to select and continuously
measure the same GUVs after repeated protein additions as well as to
discard samples with unevenly distributed eGFP-His6 within the cham-
ber or samples in which the lipid concentration varies over themeasur-
ing time (i.e. due to GUVs burst). Moreover, the lipid dynamics of each
GUV can be probed simultaneously, thus adding a further control point.
Finally, one should consider the actual measurement time of each of
these assays. In order to be able to precisely measure the average num-
ber of particles aswell as the diffusion time in the GUV–FCS approach, it
is necessary to collect data over a time period of several minutes. Thus,
the time for an experiment easily sums up when averaging several
GUVs per protein concentration. On the other hand, in both GUV-
imaging and LUV–FCS assays the actual measurement time reduces to
less than 2 h, while having approximately the same work load for
calibration and data treatment (Table 2).
5. Conclusions
The partition coefﬁcientKP is a very useful parameter to compare the
afﬁnity of anchoring segments of peripheral proteins for membranes of
different lipid compositions. Despite the variety of methods known for
determining KP, all of them possess drawbacks that could affect their
accuracy. We provide a new, complementary and versatile method to
determine KPs, which is useful in experimental situations where other
methods are not feasible and allows to directly measure membrane
afﬁnities of protein systems reconstituted in GUVs. Moreover we
showed how to understand the relation between KP and the number
of molecules per lipid surface (Eq. (8)), which can always be deter-
mined for a lipid–protein system, whose soluble protein and lipid sur-
face concentrations are known. To our knowledge, this is the ﬁrst
assay based on GUVs, which combines confocal imaging with FCS to
precisely determine protein concentrations at equilibrium. Small
amounts of sample are needed, since themeasurement can be conduct-
ed in lowvolume chambers and FCS aswell as photon-counting imaging
are known to be sensitive down to the nanomolar range. In addition, our
assay accounts for loss of protein, due for example to unspeciﬁc interac-
tions with the chamber or pipetting errors, since free and membrane
associated protein are always directly determined. Moreover, the use
of free standing membranes excludes any effects of the support on pro-
tein–lipid interaction. Apart from studying the interaction of peripheral
proteins with lipid membranes, any ﬂuorescent species, e.g. labeled
peptides or small molecules, could be investigated with this assay. In
particular, we measured the KP of the peptide corresponding to the ef-
fector domain of the MARCKS protein using the GUV–FCS approach,
and found our results to be in line with the published data using LUVs.
The comparison of our results with a FCS based LUV assay revealed
that the later method is not accurate for the NTA(Ni)-His6 system,
even when taking into account the multiple binding of peptides to a
single vesicle. Due to vesicle aggregation, no signiﬁcant increase of the
partition coefﬁcient was detected (one-way ANOVA, F(3,14) = 3.3,
p = 0.061) even in the presence of 2.5 times the amount of bindingTable 2
Comparison of the methods.
GUV–FCS GUV-imaging LUV–FCS
Measurement time per sample 5 h 2 h 2 h
Accuracy/precision High/lowa High/high Lowb/high
Accessible lipid concentration (M) 10−9–10−6 10−9–10−6 10−6–10−3 [15]
Protein concentration (M) 10−9–10−6 10−8–10−4 10−9–10−6 [15]
a If the free protein concentration is calculated only once.
b For protein-induced vesicle aggregation.sides in the membrane. The KPs obtained with our dual approach
show a dependence on the content of NTA(Ni) lipids in the membrane,
and serve as a reference for future work employing this membrane
anchoring strategy for reconstituting protein systems in GUVs.
Finally, our imaging-based GUV assay could be readily combined
with an automated GUV analysis software [56] or performed in amicro-
array setup [57] to directly extract themean intensities of several GUVs
in one image or simultaneously probe different lipid binding proteins in
a single experiment, while signiﬁcantly reducing both measuring and
analysis time.
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